Methods and products for evaluating an immune response to a therapeutic protein
US11686734B2 · kind B2 · utility
0Cited by
79References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2020 |
| Grant date | Jun 27, 2023 |
| Priority date | — |
| Expiry date | May 21, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to methods and products for the identification of a clinically significant immune response in subjects treated with a therapeutic protein. Aspects of the invention relate to methods and compositions for identifying a clinically significant immune response in patients treated with therapeutic amounts of a VLA4 binding antibody (e.g., natalizumab).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.